These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 33671547)

  • 21. Adipocytokines and hepatocellular carcinoma.
    Wieser V; Moschen AR; Tilg H
    Dig Dis; 2012; 30(5):508-13. PubMed ID: 23108307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipokines as novel modulators of lipid metabolism.
    Lago F; Gómez R; Gómez-Reino JJ; Dieguez C; Gualillo O
    Trends Biochem Sci; 2009 Oct; 34(10):500-10. PubMed ID: 19729309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity.
    Szewczyk-Golec K; Woźniak A; Reiter RJ
    J Pineal Res; 2015 Oct; 59(3):277-91. PubMed ID: 26103557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
    Orlik B; Handzlik G; Olszanecka-Glinianowicz M
    Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
    Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
    World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.
    Corbit KC; Wilson CG; Lowe D; Tran JL; Vera NB; Clasquin M; Mattis AN; Weiss EJ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipokines: a link between obesity and cardiovascular disease.
    Nakamura K; Fuster JJ; Walsh K
    J Cardiol; 2014 Apr; 63(4):250-9. PubMed ID: 24355497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in adipokines.
    Sahin-Efe A; Katsikeris F; Mantzoros CS
    Metabolism; 2012 Dec; 61(12):1659-65. PubMed ID: 23021039
    [No Abstract]   [Full Text] [Related]  

  • 29. [Novel adipokines: their potential role in the pathogenesis of obesity and metabolic disorders].
    Korek E; Krauss H
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():799-810. PubMed ID: 26206994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.
    Qureshi K; Abrams GA
    World J Gastroenterol; 2007 Jul; 13(26):3540-53. PubMed ID: 17659704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity.
    Shen C; Zhao CY; Zhang R; Qiao L
    Front Biosci (Landmark Ed); 2012 Jun; 17(6):2356-70. PubMed ID: 22652784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipokines and hepatic insulin resistance.
    Li Y; Ding L; Hassan W; Abdelkader D; Shang J
    J Diabetes Res; 2013; 2013():170532. PubMed ID: 23762871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk.
    Tumminia A; Vinciguerra F; Parisi M; Graziano M; Sciacca L; Baratta R; Frittitta L
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis.
    Tilg H
    Curr Pharm Des; 2010 Jun; 16(17):1893-5. PubMed ID: 20370678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physical activity and selected adipokines: adiponectin, leptin and resistin].
    Kopff B; Jegier A
    Pol Arch Med Wewn; 2006 Jan; 115(1):73-84. PubMed ID: 17278789
    [No Abstract]   [Full Text] [Related]  

  • 38. Obesity, adipokines and cancer: an update.
    Lee CH; Woo YC; Wang Y; Yeung CY; Xu A; Lam KS
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):147-56. PubMed ID: 25393563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?
    Scalera A; Tarantino G
    World J Gastroenterol; 2014 Jul; 20(28):9217-28. PubMed ID: 25071314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.